Evidence map›Paper›PMID 29208936›Full record

ArticleScientific reports2017

Disulfide driven folding for a conditionally disordered protein.

Hugo Fraga, Jordi Pujols, Marcos Gil-Garcia, Alicia Roque, Ganeko Bernardo-Seisdedos, Carlo Santambrogio, Joan-Josep Bech-Serra, Francesc Canals, Pau Bernadó, Rita Grandori and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Hugo FragaInstitut de Biotecnologia i Biomedicina. Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Jordi PujolsInstitut de Biotecnologia i Biomedicina. Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Marcos Gil-GarciaInstitut de Biotecnologia i Biomedicina. Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Alicia RoqueDepartament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Ganeko Bernardo-SeisdedosProtein Stability and Inherited Diseases Laboratory, CIC bioGUNE, 48160, Derio, Spain.
Carlo SantambrogioDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.
Joan-Josep Bech-SerraVall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Francesc CanalsVall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Pau BernadóCentre de Biochimie Structurale, INSERM-U1054, CNRS UMR-5048, Université de Montpellier, 29, rue de Navacelles, 34090, Montpellier, France.
Rita GrandoriDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.
Oscar MilletProtein Stability and Inherited Diseases Laboratory, CIC bioGUNE, 48160, Derio, Spain.
Salvador VenturaInstitut de Biotecnologia i Biomedicina. Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain. salvador.ventura@uab.es.ORCID 0000-0002-9652-6351
Universitat Autònoma de Barcelona · ESCIC bioGUNE · ESUniversity of Milano-Bicocca · ITVall d'Hebron Institute of Oncology · ESCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conditionally disordered proteins are either ordered or disordered depending on the environmental context. The substrates of the mitochondrial intermembrane space (IMS) oxidoreductase Mia40 are synthesized on cytosolic ribosomes and diffuse as intrinsically disordered proteins to the IMS, where they fold into their functional conformations; behaving thus as conditionally disordered proteins. It is not clear how the sequences of these polypeptides encode at the same time for their ability to adopt a folded structure and to remain unfolded. Here we characterize the disorder-to-order transition of a Mia40 substrate, the human small copper chaperone Cox17. Using an integrated real-time approach, including chromatography, fluorescence, CD, FTIR, SAXS, NMR, and MS analysis, we demonstrate that in this mitochondrial protein, the conformational switch between disordered and folded states is controlled by the formation of a single disulfide bond, both in the presence and in the absence of Mia40. We provide molecular details on how the folding of a conditionally disordered protein is tightly regulated in time and space, in such a way that the same sequence is competent for protein translocation and activity.

Indexed as

Protein FoldingAmino Acid SequenceCarrier ProteinsCopper Transport ProteinsDisulfidesHumansIntrinsically Disordered ProteinsMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsModels, MolecularProtein ConformationScattering, Small AngleSequence HomologyX-Ray DiffractionCarrier ProteinsCHCHD4 protein, humanCopper Transport ProteinsCOX17 protein, humanDisulfidesIntrinsically Disordered ProteinsMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex Proteins

Identifiers

PMID29208936
PMCPMC5717278
OpenAlexW2769429232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.